Sign in

    STERIS plc (STE)

    Financials

    Updated May 29, 2025, 9:52 PM UTC
    Income Statement - MetricFY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Total Revenues (USD, thousands)1,395,645.001,116,154.005,138,7011,279,5021,328,912.001,370,570.00--
    Gross Profit (USD, thousands)602,593.00448,577.002,218,160572,430578,791.00610,332.00--
    Total Operating Expenses (USD, thousands)386,437.00203,354.001,382,042386,899359,125.00365,039.00--
    Income from Operations (USD, thousands)216,156.00245,223.00836,118185,531219,666.00245,293.00--
    Total Non-Operating Expenses, Net (USD, thousands)36,867.0029,770.00133,30810,27224,774.0016,548.00--
    Income from Continuing Operations Before Income Tax Expense (USD, thousands)179,289.00215,453.00702,810175,259194,892.00228,745.00--
    Income Tax Expense (USD, thousands)38,344.0043,254.00149,53035,31043,506.0055,384.00--
    Income from Continuing Operations, Net of Income Tax (USD, thousands)140,945.00172,199.00553,280139,949151,386.00173,361.00--
    (Loss) Income from Discontinued Operations, Net of Income Tax (USD, thousands)--(173,201)5,592(213.00)(76.00)--
    Net Income (USD, thousands)140,945.00(1,002.00)380,079145,541151,173.00173,285.00--
    Net Income Attributable to Shareholders (USD, thousands)140,743.00(1,377.00)378,239145,401150,034.00173,534.00--
    Balance Sheet - MetricFY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Cash and cash equivalents [USD, thousands]195,585207,020207,020198,328172,195155,178171,701171,701
    Accounts receivable net [USD, thousands]964,0221,008,3151,008,315892,606923,340915,1991,043,9611,043,961
    Inventories net [USD, thousands]855,617674,535674,535698,587688,933649,558581,329581,329
    Prepaid expenses and other current assets [USD, thousands]203,729174,349174,349150,973153,401177,918203,774203,774
    Current assets held for sale [USD, thousands]-804,904804,904-----
    Total current assets [USD, thousands]2,218,9532,869,1232,869,1231,940,4941,937,8691,897,8532,000,7652,000,765
    Property plant and equipment net [USD, thousands]1,844,4841,765,1801,765,1801,834,2161,929,6661,921,7331,956,5441,956,544
    Lease right-of-use assets net [USD, thousands]195,413173,201173,201165,020159,237153,879156,388156,388
    Goodwill [USD, thousands]4,111,6834,070,7124,070,7124,056,7544,151,4374,044,1984,095,6784,095,678
    Intangibles net [USD, thousands]2,987,2872,119,2822,119,2822,048,9902,003,6691,923,0201,854,3901,854,390
    Other assets [USD, thousands]77,33566,19966,19963,12760,26767,67983,04683,046
    Total assets [USD, thousands]11,435,15511,063,69711,063,69710,108,60110,242,14510,008,36210,146,81110,146,811
    Accounts payable [USD, thousands]276,730251,723251,723231,720235,070238,298280,770280,770
    Accrued income taxes [USD, thousands]24,88013,64013,64057,0005,850-21,45621,456
    Accrued payroll and other related liabilities [USD, thousands]178,838164,831164,831149,372146,575160,785192,677192,677
    Short-term lease obligations [USD, thousands]36,71131,23931,23929,70530,50932,45134,20234,202
    Short-term indebtedness [USD, thousands]78,43885,93885,93880,00080,000125,000125,000125,000
    Accrued expenses and other [USD, thousands]318,097319,744319,744286,563307,479334,586368,068368,068
    Current liabilities held for sale [USD, thousands]-64,01264,012-----
    Total current liabilities [USD, thousands]913,694931,127931,127834,360805,483891,1201,022,1731,022,173
    Long-term indebtedness [USD, thousands]3,231,0753,120,1623,120,1622,235,6012,156,1582,038,7251,918,7011,918,701
    Deferred income taxes net [USD, thousands]621,071479,688479,688456,465462,741453,125403,654403,654
    Long-term lease obligations [USD, thousands]162,827145,828145,828139,362133,148123,717124,637124,637
    Other liabilities [USD, thousands]78,38971,54671,54672,36874,15373,12961,88961,889
    Total liabilities [USD, thousands]5,007,0564,748,3514,748,3513,738,1563,631,6833,579,8163,531,0543,531,054
    Ordinary shares [USD, thousands]4,534,2594,543,1764,543,1764,499,5804,490,9994,404,6874,420,4134,420,413
    Retained earnings [USD, thousands]2,133,7662,087,6452,087,6452,178,0872,268,3262,385,6642,475,3302,475,330
    Accumulated other comprehensive loss [USD, thousands](252,629)(328,657)(328,657)(323,070)(165,836)(374,250)(292,338)(292,338)
    Total shareholders’ equity [USD, thousands]6,415,3966,302,1646,302,1646,354,5976,593,4896,416,1016,603,4056,603,405
    Noncontrolling interests [USD, thousands]12,70313,18213,18215,84816,97312,44512,35212,352
    Total equity [USD, thousands]6,428,0996,315,3466,315,3466,370,4456,610,4626,428,5466,615,7576,615,757
    Total liabilities and equity [USD, thousands]11,435,15511,063,69711,063,69710,108,60110,242,14510,008,36210,146,81110,146,811
    Cash Flow - MetricFY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Net income (USD, thousands)140,945.00(1,002.00)380,079145,541151,173.00173,285.00--
    Depreciation, depletion, and amortization (USD, thousands)140,629.00134,438.00565,244112,698115,255.00125,913.00--
    Deferred income taxes (USD, thousands)808.00(130,906.00)(131,412)(22,121)36.00(1,702.00)--
    Share-based compensation expense (USD, thousands)15,293.008,947.0056,53511,46020,812.0015,334.00--
    Loss (gain) on the disposal of property, plant, equipment, and intangibles, net (USD, thousands)132.0025,968.0024,9972,151548.00305.00--
    Gain on sale of businesses and equity investment, net (USD, thousands)---(10,960)6,502.00(15.00)--
    Gain on sale of businesses, net (USD, thousands)--873-----
    Gain on sale of investments (USD, thousands)--(546)-----
    Amortization of inventory fair value adjustments (USD, thousands)-100.004,822-----
    Other items (USD, thousands)4,423.007,780.0012,316(2,451)3,037.00(7,742.00)--
    Net cash provided by operating activities (USD, thousands)291,243.00254,807.00973,274303,743250,725.00332,838.00--
    Purchases of property, plant, equipment, and intangibles, net (USD, thousands)(118,936.00)(91,497.00)(360,326)(108,083)(101,892.00)(89,231.00)--
    Proceeds from the sale of property, plant, equipment, and intangibles (USD, thousands)15.00-------
    Proceeds from the sale of businesses (USD, thousands)0.000.009,458809,571348.001,515.00--
    Acquisition of businesses, net of cash acquired (USD, thousands)0.00(6,498.00)(546,256)(13,659)(3,808.00)(36,192.00)--
    Net cash provided by (used in) investing activities (USD, thousands)(118,921.00)(95,607.00)(887,361)687,829(105,352.00)(123,904.00)--
    Payments on Private Placement Senior Notes (USD, thousands)--------
    Payments on term loans (USD, thousands)(15,000.00)(15,000.00)(60,000)(638,125)0.000.00--
    (Payments) proceeds under credit facilities, net (USD, thousands)(125,521.00)(84,015.00)181,486(253,200)(91,720.00)25,928.00--
    Deferred financing fees and debt issuance costs (USD, thousands)--------
    Acquisition related deferred or contingent consideration (USD, thousands)(5,976.00)(89.00)(6,242)(87)(90.00)(89.00)--
    Repurchases of ordinary shares (USD, thousands)(2,227.00)(325.00)(11,765)(64,203)(46,422.00)(100,433.00)--
    Cash dividends paid to ordinary shareholders (USD, thousands)(51,378.00)(51,397.00)(200,570)(51,436)(56,237.00)(56,196.00)--
    Distributions to noncontrolling interest holders (USD, thousands)-0.00(1,561)-----
    Contributions from noncontrolling interest holders (USD, thousands)-111.002,9942,5320.000.00--
    Stock option and other equity transactions, net (USD, thousands)786.006,946.0010,4725,58713,505.00288.00--
    Net cash (used in) provided by financing activities (USD, thousands)(197,994.00)(143,769.00)(85,186)(998,932)(180,964.00)(214,397.00)--
    Effect of exchange rate changes on cash and cash equivalents (USD, thousands)7,500.00(3,996.00)(2,064)(1,332)9,458.00(11,554.00)--
    (Decrease) increase in cash and cash equivalents (USD, thousands)(18,172.00)11,435.00(1,337)(8,692)(26,133.00)(17,017.00)--
    Loss on classification as held for sale (USD, thousands)--206,444-----
    Fair value adjustment related to convertible debt, premium liability (USD, thousands)--------
    Goodwill impairment loss (USD, thousands)--------
    Proceeds from issuance of senior public notes (USD, thousands)--------
    Proceeds from term loans (USD, thousands)--------
    Payments on convertible debt (USD, thousands)--------
    Accounts receivable, net (USD, thousands)(18,252)(128,069)(128,069)107,68382,50679,295--
    Inventories, net (USD, thousands)(123,349)(37,450)(37,450)(34,134)(18,677)(727)--
    Other current assets (USD, thousands)(22,841)(1,552)(1,552)9,4388,565(18,353)--
    Accounts payable (USD, thousands)(6,097)(18,962)(18,962)(17,122)(16,261)(7,504)--
    Accruals and other, net (USD, thousands)21,75039,95539,9551,560(35,346)(4,464)--
    Cash and cash equivalents at beginning of period (USD, thousands)208,357208,357208,357207,020207,020207,020--
    Cash and cash equivalents at end of period (USD, thousands)195,585207,020207,020198,328172,195155,178--
    Investment in convertible notes (USD, thousands)-(1,500)(1,500)-----
    Revenue by Segment - in Millions of USDFY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Healthcare916.21,007.83,613.0901.2944.2976.01,057.33,878.7
    - Capital Equipment--155.526.523.031.136.9117.5
    - Consumables--251.669.872.168.776.1286.7
    - Service--164.632.232.836.636.5138.1
    AST234.9250.9954.0249.8256.7258.12741,038.6
    Life Sciences146.6160.6571.7128.5127.9136.4149.5542.3
    Dental97.9-------
    Product Revenue--2,764.0656.3695.9718.3801.12,871.6
    Service Revenue--2,374.7623.2633.0652.2679.52,587.9
    Total Revenue1,395.61,116.25,138.71,279.51,328.91,370.61,480.55,459.5
    Revenue by Geography - in Millions of USDFY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Ireland19.65122.5582.722.222.824.138.2107.3
    United States1,025.458802.543,751.4946.9979.51,002.61,078.64,007.6
    Other Foreign Locations350.536291.161,304.6310.4326.6343.9363.71,344.6
    Total Revenue1,395.6451,116.155,138.71,279.51,328.91,370.61,480.55,459.5
    KPIs - Metric (Unit, Scale)FY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025
    Backlog in Healthcare segment (millions of USD)449.4-353.8362.0405.3---
    Backlog in Life Sciences segment (millions of USD)85.0-71.4-75.6---